Navigation Links
NTI in Medical News

National Trauma Institute Announces 15th Annual Trauma Symposium in San Antonio, August 31-September 1

...n, MD, University of Pittsburgh Medical Center; Dr. Ronald Stewart, MD, FACS, University of Texas Health Science Center at San Antonio and nti Board Chairman COL Lorne Blackbourne, Commander U.S. Army Institute of Surgical Research Registration information and confer...

ARTHUR(R) and CVS Caremark Debut the Winner of the 'ARTHUR/All Kids Can Character Search' June 30 on PBS KIDS GO!(SM)

...RTHUR ARTHUR, based on Marc Brown's best-selling books, is the highest rated weekday children's series on PBS among children 6-11 (Source: For PBS, nti Pocketpiece, October 2007-June 2008). ARTHUR has won numerous awards, including the George Foster Peabody Award, a BAFTA and six Daytime Emmys--four f...

Neurobiological Technologies Reports Third Quarter Fiscal 2009 Financial Results

...e 3 clinical trials as a potential new drug to treat acute ischemic stroke. nti has more recently chosen not to extend its early-stage research programs for Huntington's and Alzheimer's diseases. nti has rights to receive payments from an approved drug for Alzheimer's diseas...

Cherrybrook Kitchen Announces New Partnership With Arthur

...HUR ARTHUR, based on Marc Brown's best-selling books, is the highest rated weekday children's series on PBS among children 6-11 (Source: For PBS, nti Pocketpiece, October 2007-June 2008). ARTHUR has won numerous awards, including the George Foster Peabody Award, a BAFTA and six Daytime Emmys -- four...

Neurobiological Technologies Announces Appointment of William A. Fletcher as Acting CEO

...mpany's Acting Chief Executive Officer. Mr. Fletcher has been a director of nti since February 2007. With the Acting CEO appointment, the board of director...linical trials for evaluation as a new drug to treat acute ischemic stroke. nti has an early-stage development program for Alzheimer's disease and rights t...

Food and Drug Law Institute Sponsors Major Conference on Nanotechnology Law, Regulation and Policy

...s Michael J. Kosnett , University of Colorado, Denver and Colorado School of Public Health Erli Chen , Nanotechnology Commercialization Group, nti Gary Marchant , Arizona State University Diana Bowman , Monash University Steffi Friedrichs , Nanotechnology Industries Association John...

Neurobiological Technologies Reports Second Quarter Financial Results

...e well tolerated for acute ischemic stroke. Conference Call Information nti will webcast its quarterly financial results and host a conference call on .... Replay access code: 3898964. About Neurobiological Technologies, Inc. nti is a biopharmaceutical company focused on developing novel agents for centr...

Dr. Warren Wasiewski Appointed Chief Medical Officer of Neurobiological Technologies, Inc.

... Medical Officer, effective as of November 26, 2007. Dr. Wasiewski joined nti in February 2007 as Vice President, Clinical Programs with primary responsi...rsity of New York, at Buffalo. About Neurobiological Technologies, Inc. nti is a specialty biopharmaceutical company with expertise in identifying and ...

Neurobiological Technologies Announces Compliance With Nasdaq Listing Standards

...DAQ Listing Qualifications Department had notified nti that it was not in compliance with the $35 million...f listed securities continued listing requirement. nti regained compliance following the closing on Novem... stock. About Neurobiological Technologies, Inc. nti is a specialty biopharmaceutical company with expe...

Neurobiological Technologies Reports $2.1 Million Quarterly Payment for Sales of Memantine

...nd a 6% increase over last quarter. Under an exclusive marketing agreement, nti receives quarterly royalty payments on sales of Memantine by Merz and its marketing partners. About Neurobiological Technologies, Inc. nti is a specialty biopharmaceutical company with expertise in identifying and ...

Neurobiological Technologies, Inc. Announces Receipt of Determination Letter from NASDAQ

...ment on Form S-1 filed with the SEC on August 13, 2007. This offering is expected to close in October 2007. About Neurobiological Technologies, Inc. nti is a specialty biopharmaceutical company with expertise in identifying and acquiring promising drug candidates and in designing and managing late-stag...

Neurobiological Technologies Reports Going Concern Qualification

...in identifying and acquiring promising drug candidates and in designing and managing late-stage clinical trials for central nervous system conditions. nti is currently developing Viprinex, a novel reperfusion agent that is in pivotal Phase 3 trials for the treatment of acute ischemic stroke. Forward-Loo...
Other Tags
(Date:7/8/2015)... 2015  Trovagene, Inc. (NASDAQ: TROV ), ... the launch of a study that aims to ... (PCM) technology for predicting response to treatment in ... of the novel immunotherapy agents Yervoy® (ipilumumab), a ... The 50-patient study will be led by researchers ...
(Date:7/2/2015)... 25, 2015 Research ... of the "Natural Language Processing Market by ... OCR, Pattern & Image Recognition) - Worldwide Forecast ... The key vendors occupying the market are ... Microsoft Corporation, NetBase Solutions, SAS Institute Inc., Verint ...
(Date:6/29/2015)... 2015 Research and Markets( ... "Latin America Biomedical Sensors Market - Growth, Trends & ... The Latin America Biomedical Sensors market is estimated at ... over the period 2014-2020 The near future ... genetic formulation of each individual. These sensors can be ...
Breaking Biology News(10 mins):Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 2Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 3Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 4Natural Language Processing Market by Type (Rule-Based, Statistical, and Hybrid), Technologies (Recognition, IVR, OCR, Pattern & Image Recognition) - Worldwide Forecast to 2020 2Latin America Biomedical Sensors Market Report 2015-2020 2
(Date:7/28/2015)... ... July 28, 2015 , ... Safeguard Scientifics, Inc. (NYSE:SFE) ... from time to time and depending on market conditions, to repurchase shares of ... Repurchases will be made in open market or privately negotiated transactions in compliance ...
(Date:7/28/2015)... , ... July 28, 2015 , ... ... to include a proprietary, web based clinical knowledge system, called “Referral Guidance.” ... based. It provides physicians who are anticipating making a subspecialty referral an ...
(Date:7/28/2015)... ... July 28, 2015 , ... Fertility specialist Dr. ... “Top Doctor 2015” by Atlanta Magazine. In Atlanta Magazine's annual Top Doctors issue, Dr. ... her esteemed colleagues and peers in the metro area as one of the most ...
(Date:7/28/2015)... ... July 28, 2015 , ... A new study published by HealthDay News ... " sheds light on a possible new treatment option for people living with fibromyalgia ... HBOT sessions, at least five per week, patients experienced a significant decrease in pain, ...
(Date:7/28/2015)... Irvine, CA (PRWEB) , ... July 28, 2015 ... ... risk of Acute Coronary Syndromes (ACS-Heart Attack, Sudden Death, or Angina), many of ... clinical cardiology is the identification of individuals with active yet undetected sub-clinical disease, ...
Breaking Medicine News(10 mins):Health News:Safeguard Scientifics Board of Directors Authorizes up to $25 Million Share Repurchase Program 2Health News:Safeguard Scientifics Board of Directors Authorizes up to $25 Million Share Repurchase Program 3Health News:Introducing Care to Care’s New Web Based “Referral Guidance” Program 2Health News:Atlanta Fertility Specialist Named Top Doctor in Atlanta Magazine 2Health News:Atlanta Fertility Specialist Named Top Doctor in Atlanta Magazine 3Health News:Recovery Specialists Discuss How Oxygen Therapy Can Ease Fibromyalgia 2Health News:Recovery Specialists Discuss How Oxygen Therapy Can Ease Fibromyalgia 3Health News:Utility of a novel coronary artery disease biomarker algorithm in modifying physician adherence to guideline therapy presented at 20th World Congress on Heart Disease 2
Other Contents